This is the preview version of the Wisconsin State Legislature site.
Please see http://docs.legis.wisconsin.gov for the production version.
LRB-0993/1
TJD&MPG:kjf:kf
2015 - 2016 LEGISLATURE
May 5, 2015 - Introduced by Representatives Edming, Kremer, Berceau,
Brandtjen, Considine, Danou, Horlacher, Hutton, Jacque, Kleefisch,
Knodl, Kulp, T. Larson, Murphy, Petryk, Quinn, Ripp, Rohrkaste, Spreitzer,
Subeck and Tittl, cosponsored by Senators Vukmir, Cowles, Harris Dodd,
Lassa, Miller, Moulton, Nass and Vinehout. Referred to Committee on
Health.
AB203,1,3 1An Act to amend 448.03 (2) (q), 450.11 (1), 450.11 (3) and 450.11 (4) (a) 5. a.; and
2to create 255.07 and 450.11 (4) (a) 5. d. of the statutes; relating to: supply and
3use of epinephrine auto-injectors by certain authorized entities.
Analysis by the Legislative Reference Bureau
Under current law, a physician, an advanced practice nurse prescriber, or a
physician assistant may prescribe epinephrine auto-injectors in the name of a school
that has adopted a plan for the management of pupils with life-threatening
allergies. The governing body of such a school may authorize a school nurse or other
school personnel to: 1) provide an epinephrine auto injector to a pupil for that pupil
to self-administer in accordance with that pupil's prescription; 2) administer an
epinephrine auto-injector to a pupil in accordance with that pupil's prescription; or
3) administer an epinephrine auto-injector to a pupil or other person who the nurse
or other personnel believes to be experiencing anaphylaxis according to a standing
protocol regardless whether the pupil or other person has a prescription for an
epinephrine auto-injector. This bill allows a physician, physician assistant, or
advance practice nurse prescriber to prescribe an epinephrine auto-injector in the
name of any entity or organization, other than a school, operating a business,
activity, or event at which allergens capable of causing anaphylaxis may be present
(authorized entity), including a camp, college, university, day care facility, youth
sports league, amusement park, restaurant, place of employment, and sports arena.
The authorized entity may acquire and maintain a supply of epinephrine
auto-injectors and must store the epinephrine auto-injectors in a location readily

accessible in an emergency and in accordance with the instructions for using an
epinephrine auto-injector and any requirements established by the Department of
Health Services. The bill requires the authorized entity to designate an employee
or agent who has completed the training required under the bill to be responsible for
the storage, maintenance, control, and oversight of the epinephrine auto-injectors.
The bill allows an employee or agent of an authorized entity or other individual
who has completed the training required under the bill to either provide or
administer an epinephrine auto-injector to an individual who the employee, agent,
or other individual believes is experiencing anaphylaxis regardless of whether that
individual has a prescription for an epinephrine auto-injector or has been diagnosed
with an allergy. Among other liability protections, the bill exempts from liability for
any injury that results from the administration or failure to administer an
epinephrine auto-injector, all of the following: an authorized entity that possesses
and makes available an epinephrine auto-injector; employees and agents of the
authorized entity or other individuals that store, maintain, control, oversee, provide,
or use an epinephrine auto-injector; a health care practitioner who prescribes or
dispenses an epinephrine auto-injector to an authorized entity; a pharmacist or
other person who dispenses an epinephrine auto-injector to an authorized entity;
and a person who provides the training required under the bill.
For further information see the state fiscal estimate, which will be printed as
an appendix to this bill.
The people of the state of Wisconsin, represented in senate and assembly, do
enact as follows:
AB203,1 1Section 1. 255.07 of the statutes is created to read:
AB203,2,4 2255.07 Life-saving allergy medication; use of epinephrine
3auto-injectors.
(1) Definitions. (a) "Administer" means the direct application of
4an epinephrine auto-injector to the body of an individual.
AB203,2,95 (b) "Authorized entity" means any entity or organization, other than a school
6described in s. 118.2925, operating a business, activity, or event at which allergens
7capable of causing anaphylaxis may be present, including a recreational and
8educational camp, college, university, day care facility, youth sports league,
9amusement park, restaurant, place of employment, and sports arena.
AB203,3,3
1(c) "Epinephrine auto-injector" means a device for the automatic injection of
2epinephrine into the human body to prevent or treat a life-threatening allergic
3reaction.
AB203,3,64 (d) "Health care practitioner" means a physician, a physician assistant licensed
5under s. 448.04 (1) (f), or an advanced practice nurse who is certified to issue
6prescription orders under s. 441.16.
AB203,3,9 7(2) Prescribing to an authorized entity permitted. A health care practitioner
8may prescribe an epinephrine auto-injector in the name of an authorized entity for
9use in accordance with this section.
AB203,3,18 10(3) Authorized entities permitted to maintain supply. An authorized entity
11may acquire and maintain a supply of epinephrine auto-injectors pursuant to a
12prescription issued in accordance with this section. The authorized entity shall store
13an epinephrine auto-injector in a location readily accessible in an emergency and in
14accordance with the epinephrine auto-injector's instructions for use and any
15additional requirements that may be established by the department. An authorized
16entity shall designate an employee or agent who has completed the training required
17in sub. (5) to be responsible for the storage, maintenance, control, and general
18oversight of epinephrine auto-injectors acquired by the authorized entity.
AB203,3,21 19(4) Use of epinephrine auto-injectors. An employee or agent of an authorized
20entity, or other individual, who has completed the training required by sub. (5) may
21use an epinephrine auto-injector prescribed under sub. (2) to do any of the following:
AB203,4,222 (a) Provide one or more epinephrine auto-injectors to any individual who the
23employee, agent, or individual believes in good faith is experiencing anaphylaxis, or
24to the parent, guardian, or caregiver of that individual for immediate

1administration, regardless of whether the individual has a prescription for an
2epinephrine auto-injector or has previously been diagnosed with an allergy.
AB203,4,63 (b) Administer an epinephrine auto-injector to any individual who the
4employee, agent or other individual believes in good faith is experiencing
5anaphylaxis, regardless of whether the individual has a prescription for an
6epinephrine auto-injector or has previously been diagnosed with an allergy.
AB203,4,13 7(5) Training. (a) An employee, agent, or other individual described in sub. (3)
8or (4) shall complete an anaphylaxis training program and at least every 4 years
9thereafter. The employee, agent, or other individual shall complete a training
10program conducted by a nationally recognized organization experienced in training
11laypersons in emergency health treatment or a person approved by the department.
12The department may approve specific persons or classes of persons to conduct
13training, either online or in person, that covers, at a minimum, all of the following:
AB203,4,1514 1. How to recognize signs and symptoms of severe allergic reactions, including
15anaphylaxis.
AB203,4,1716 2. Standards and procedures for the storage and administration of an
17epinephrine auto-injector.
AB203,4,1918 3. Emergency follow-up procedures after an epinephrine auto-injector is
19administered.
AB203,4,2220 (b) The person that conducts the training under par. (a) shall issue a certificate,
21on a form developed or approved by the department, to each person who successfully
22completes the anaphylaxis training program.
AB203,5,2 23(6) Good Samaritan protections. (a) All of the following are not liable for any
24injury that results from the administration or failure to administer an epinephrine

1auto-injector under this section, unless the injury is the result of an act or omission
2that constitutes gross negligence or willful or wanton misconduct:
AB203,5,53 1. An authorized entity that possesses and makes available an epinephrine
4auto-injector and its employees, agents, and other individuals that store, maintain,
5control, oversee, provide, or use an epinephrine auto-injector.
AB203,5,76 2. A health care practitioner who prescribes or dispenses an epinephrine
7auto-injector to an authorized entity.
AB203,5,98 3. A pharmacist or other person who dispenses an epinephrine auto-injector
9to an authorized entity.
AB203,5,1010 4. A person who conducts the training described in sub. (5).
AB203,5,1311 (b) The use of an epinephrine auto-injector under this section does not
12constitute the practice of medicine or of any other health care profession that
13requires a credential to practice.
AB203,5,1614 (c) This immunity from liability or defense provided under this subsection is
15in addition to and not in lieu of that provided under s. 895.48 or any other defense
16or liability provided under state law.
AB203,5,1917 (d) A person is not liable for any injuries or related damages that result from
18providing or administering an epinephrine auto-injector outside of this state if the
19person satisfies any of the following criteria:
AB203,5,2120 1. The person would not have been liable for injuries or damages if the
21epinephrine auto-injector was provided or administered in this state.
AB203,5,2322 2. The person is not liable for injuries or damages under the law of the state
23in which the epinephrine auto-injector was provided or administered.
AB203,2 24Section 2. 448.03 (2) (q) of the statutes is amended to read:
AB203,6,2
1448.03 (2) (q) The administration of an epinephrine auto-injector in
2accordance with s. 118.2925 or 255.07.
AB203,3 3Section 3. 450.11 (1) of the statutes is amended to read:
AB203,6,164 450.11 (1) Dispensing. Except as provided in sub. (1i) (b) 2., no person may
5dispense any prescribed drug or device except upon the prescription order of a
6practitioner. All prescription orders shall specify the date of issue, the name and
7address of the practitioner, the name and quantity of the drug product or device
8prescribed, directions for the use of the drug product or device, the symptom or
9purpose for which the drug is being prescribed if required under sub. (4) (a) 8., and,
10if the order is written by the practitioner, the signature of the practitioner. Except
11as provided in ss. 118.2925 (3) and, 255.07 (2), 441.18 (2), 448.035 (2), and 448.037
12(2), all prescription orders shall also specify the name and address of the patient. A
13prescription order issued under s. 118.2925 (3) shall specify the name and address
14of the school. A prescription order issued under s. 255.07 (2) shall specify the name
15and address of the authorized entity.
Any oral prescription order shall be
16immediately reduced to writing by the pharmacist and filed according to sub. (2).
AB203,4 17Section 4. 450.11 (3) of the statutes, as affected by 2015 Wisconsin Act 3, is
18amended to read:
AB203,6,2319 450.11 (3) Preparation of prescription drugs. Except as provided in sub. (1i)
20(b) and s. ss. 118.2925 (4), 255.07 (3), and 450.076, no person other than a pharmacist
21or practitioner or their agents and employees as directed, supervised, and inspected
22by the pharmacist or practitioner may prepare, compound, dispense, or prepare for
23delivery for a patient any prescription drug.
AB203,5 24Section 5. 450.11 (4) (a) 5. a. of the statutes is amended to read:
AB203,7,2
1450.11 (4) (a) 5. a. Except as provided in subd. 5. b. and c. to d., the full name
2of the patient.
AB203,6 3Section 6. 450.11 (4) (a) 5. d. of the statutes is created to read:
AB203,7,64 450.11 (4) (a) 5. d. For an epinephrine auto-injector prescribed under s.
5118.2925 (3) or 255.07 (2), the name of the school, authorized entity, or other person
6specified under s. 255.07 (3).
AB203,7,77 (End)
Loading...
Loading...